ResearchA Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.
ResearchA blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada.
ResearchOpen-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
ResearchSex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance).
ResearchDifferent diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis.
ResearchUltraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women.
ResearchProtein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
ResearchBiomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.